Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
There is no validated, publicly available reconstitution protocol for retatrutide, as it is an unlicensed investigational compound in the UK that may only be prepared by trained personnel within an approved clinical trial
Retatrutide targets three hormone receptors simultaneously (GLP-1, GIP, and glucagon), distinguishing it from approved agents such as semaglutide (GLP-1 agonist) and tirzepatide (dual GIP/GLP-1 agonist)
When combined with semi-quantitative ultrasonographic approaches such as the US-FLI, this dual-modality framework allows for real-time visualization of hepatic steatosis and steatohepatitis alongside biomarker-driven estimation of fibrosis severity and cardiometabolic risk 78,79
Since it enhances growth hormone production, its prohibited in professional and competitive sports
US$ 25.57
US$ 27.59
US$ 25.63
US$ 28.36
US$ 29.47
US$ 25.03
